You are viewing: US Peritoneal Dialysis Market analysis
Part of: Peritoneal Dialysis Market (Global)

The US Peritoneal Dialysis Market was valued at $1425.6 Million in 2026 and projected to reach to $1863.7 Million by 2031, representing a compound annual growth rate of 5.5%. The US peritoneal dialysis market is positioned for sustained growth through 2031, driven by rising ESRD prevalence, technological advancements in dialysis equipment, and favorable reimbursement policies from Medicare and private insurers.

US Peritoneal Dialysis Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Peritoneal Dialysis Market Trends and Insights

  • This steady expansion reflects increasing adoption of peritoneal dialysis as a preferred renal replacement therapy in the US, driven by rising prevalence of end-stage renal disease and growing patient preference for home-based dialysis solutions.
  • The US market benefits from advanced healthcare infrastructure, strong reimbursement frameworks, and continuous innovation in dialysis technology and treatment protocols. During the forecast period from 2026 to 2031, the US peritoneal dialysis market is expected to experience sustained growth supported by demographic shifts, improved clinical outcomes, and expanding access to peritoneal dialysis training and support services across US healthcare facilities.
  • The US market's growth trajectory is underpinned by favorable regulatory environments and increasing investment in nephrology care.
  • As the US healthcare system continues to prioritize cost-effective and patient-centric dialysis modalities, peritoneal dialysis is positioned to capture a larger share of the overall dialysis market..

Key Market Statistics

  • CAGR (2026-2031) 5.5% CAGR
  • Market Size, 2026 ~USD 1425.6 Million
  • Forecast, 2031 ~USD 1863.7 Million
  • Country US

US Peritoneal Dialysis Market Overview

Market Size & Growth :

The US peritoneal dialysis market is valued at $1,425.6 million in 2026 and is projected to reach $1,863.7 million by 2031, with a CAGR of 5.5%, reflecting strong market expansion driven by clinical and patient preference trends.

Rising ESRD Prevalence :

Increasing incidence of end-stage renal disease in the US population, coupled with aging demographics and higher rates of diabetes and hypertension, is driving demand for peritoneal dialysis as a viable renal replacement therapy option.

Home-Based Treatment Preference :

Growing patient preference for home-based peritoneal dialysis over in-center hemodialysis is accelerating market adoption, supported by improved quality of life, greater autonomy, and reduced healthcare facility burden in the US healthcare system.

Healthcare Infrastructure Investment :

Increased investment in US dialysis centers, training programs, and home-based care infrastructure is expanding access to peritoneal dialysis, particularly in underserved regions and among diverse patient populations.

US Peritoneal Dialysis Market Dynamics

  • Patient education initiatives and clinical evidence supporting peritoneal dialysis efficacy are expected to increase adoption rates among newly diagnosed renal failure patients.
  • Healthcare providers are increasingly recognizing peritoneal dialysis as a cost-effective alternative to hemodialysis, particularly for home-based treatment models.
  • Continued innovation in biocompatible dialysate solutions and automated peritoneal dialysis systems will further enhance market penetration across diverse US patient demographics..

Market Ecosystem

logo-mobile

PERITONEAL DIALYSIS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
A global leader in kidney care offering a comprehensive peritoneal dialysis portfolio, including automated peritoneal dialysis (APD) cyclers, PD solutions, consumables, and digital therapy management platforms. The company supports home-based dialysis through extensive training, remote monitoring, and a strong global clinical network across North America, Europe, Asia Pacific, Latin America, and the Middle East. Improves treatment efficiency and patient independence through advanced APD technologies. Enhances therapy adherence, reduces infection risks with standardized protocols, and enables remote patient monitoring for better clinical outcomes and quality of life.
A dedicated kidney care company providing a broad portfolio of APD systems, CAPD solutions, PD cyclers, dialysis solutions, transfer sets, and digital renal care technologies. Vantive focuses on expanding access to home dialysis through connected care platforms, clinician education, and patient support programs across developed and emerging markets. Enables personalized home dialysis, improves treatment continuity, and enhances patient comfort. Connected care solutions support remote monitoring, optimize therapy adherence, and improve long-term clinical outcomes while reducing healthcare resource utilization.
Offers advanced PD access products including catheters, transfer sets, connectors, needles, and infection-prevention technologies used in peritoneal dialysis procedures. The company's products support safe catheter placement and standardized PD practices across hospitals and home-care settings. Minimizes catheter-related complications and peritonitis risk while improving procedural safety and reliability. Supports efficient PD initiation and maintenance, enhancing patient safety and reducing treatment interruptions.
Provides minimally invasive vascular access technologies, guidewires, introducers, catheters, and surgical products that facilitate safe placement and management of peritoneal dialysis catheters. The company leverages advanced medical device expertise to support renal access procedures worldwide. Enhances procedural success, improves catheter placement accuracy, and reduces access-related complications. Reliable device performance supports broader adoption of peritoneal dialysis and improves clinician confidence during implantation procedures.
One of the world's leading dialysis service providers offering comprehensive home-based peritoneal dialysis programs supported by patient education, clinical training, remote monitoring, and integrated kidney care services. DaVita emphasizes value-based care and multidisciplinary care coordination to expand PD adoption. Increases access to home-based dialysis, improves patient engagement and treatment adherence, and supports personalized care pathways. Integrated care models reduce hospitalization rates, improve long-term patient outcomes, and enhance overall healthcare cost efficiency.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • The US peritoneal dialysis market is valued at $1,425.6 million in 2026 and will reach $1,863.7 million by 2031 at a 5.5% CAGR.
    • The US market is driven by rising end-stage renal disease prevalence and patient preference for home-based dialysis therapies.
    • Strong US healthcare infrastructure and reimbursement policies support sustained market expansion through 2031.
    • The US peritoneal dialysis market benefits from continuous technological innovation and expanded clinical training programs.

    Peritoneal Dialysis Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment PERITONEAL DIALYSIS MACHINES (Type)
    Forecast Period 2026-2031
    Growth Rate CAGR of 6% from 2026 to 2031
    Largest Segment PRODUCTS (Offering)
    Market Size Base Year (Billions) ~USD 10.58 (2026)
    Revenue Forecast (Billions) ~USD 14.16 (2031)
    Segments Covered Offering, Type, Modality, Disease Indication, End User

    US Peritoneal Dialysis Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Offering

    • Products
    • Services

    By Type

    • Other Peritoneal Dialysis Products
    • Peritoneal Dialysis Catheters
    • Peritoneal Dialysis Machines
    • Peritoneal Dialysis Solution Bags
    • Peritoneal Dialysis Transfer Sets

    By Modality

    • Automated Peritoneal Dialysis
    • Continuous Ambulatory Peritoneal Dialysis (Capd)

    By Disease Indication

    • Acute Kidney Injury
    • End-Stage Renal Disease
    • End-Stage Renal Diseases
    • Other Diseases

    By End User

    • Homecare
    • Hospitals & Independent Dialysis Centers
    • Other End Users

    Target Audience

    • Medical Device Manufacturers : Peritoneal dialysis equipment and supplies manufacturers need US market data to assess market opportunity, competitive positioning, pricing strategies, and regional expansion plans within the American healthcare system.
    • Healthcare Providers & Dialysis Centers : US-based dialysis clinics and hospital networks require market insights to evaluate peritoneal dialysis service expansion, capital investment decisions, and patient recruitment strategies aligned with market growth trends.
    • Pharmaceutical Companies : Dialysate solution and medication manufacturers need US-specific market data to guide product development, clinical trial planning, and commercialization strategies for the American peritoneal dialysis patient population.
    • Healthcare Investors & Consultants : Private equity firms, healthcare consultants, and investment analysts require detailed US market forecasts and growth drivers to evaluate investment opportunities and advise clients on peritoneal dialysis sector dynamics.
    • Policymakers & Health Administrators : US government health agencies and hospital administrators need market data to inform reimbursement policies, healthcare resource allocation, and strategic planning for end-stage renal disease management programs.

    Reasons to Buy this Report

    • Market Size & Forecast Data : Access precise US market valuations ($1,425.6M in 2026 to $1,863.7M in 2031) with detailed CAGR analysis to support strategic planning, investment decisions, and competitive positioning in the American peritoneal dialysis sector.
    • US-Specific Growth Drivers : Understand unique American market dynamics including ESRD prevalence trends, patient preference shifts toward home-based therapy, and healthcare policy impacts that differentiate the US market from global trends.
    • Competitive Landscape Intelligence : Identify key players, market share distribution, and competitive strategies specific to the US peritoneal dialysis market to inform product development, partnership opportunities, and market entry strategies.
    • Regulatory & Reimbursement Insights : Gain detailed knowledge of US Medicare/Medicaid reimbursement policies, FDA regulations, and healthcare infrastructure requirements essential for market success and profitability in the American dialysis market.
    • Patient Segmentation & Demand Analysis : Leverage US-specific demographic data, patient behavior patterns, and regional adoption variations to optimize marketing strategies, product positioning, and distribution channels for maximum market penetration.

    Frequently asked questions

    What is the current size of the US peritoneal dialysis market in 2026?

    The US peritoneal dialysis market is estimated at $1,425.6 million in 2026.

    What is the projected size of the US peritoneal dialysis market by 2031?

    The US peritoneal dialysis market is projected to reach $1,863.7 million by 2031.

    What is the CAGR for the US peritoneal dialysis market from 2026 to 2031?

    The US peritoneal dialysis market is expected to grow at a compound annual growth rate of 5.5% from 2026 to 2031.

    What factors are driving growth in the US peritoneal dialysis market?

    Growth in the US peritoneal dialysis market is driven by rising end-stage renal disease prevalence, patient preference for home-based dialysis, advanced healthcare infrastructure, and strong reimbursement frameworks.

    Why is peritoneal dialysis gaining adoption in the US?

    Peritoneal dialysis is gaining adoption in the US due to its cost-effectiveness, patient convenience as a home-based therapy, improved clinical outcomes, and expanding access to training and support services.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the peritoneal dialysis market. Exhaustive secondary research was done to collect information on the Peritoneal dialysis market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the Peritoneal dialysis market.

    Secondary Research

    This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the Peritoneal dialysis market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, VPs/Managing Directors, Marketing Heads/Directors, Sales Directors, Marketing/Sales Managers, Regional/Area Sales Managers, Export/Import Heads/Managers, and Other Peritoneal dialysis Market Related Personnel from various companies and organizations operating in the Peritoneal dialysis market. Primary sources from the demand side included Vice Presidents, C-level Executives, Department Heads, Enterprises, Individuals, Supply Management Team of Hospitals, Clinic Personnel, and Laboratory Technicians.

    Breakdown of Primary Interviews

    Peritoneal Dialysis Market Size, and Share

    Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.
    Note 2: Other primary roles include sales, marketing, and product management.
    Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the Peritoneal dialysis market. These methods were also used extensively to estimate the sizes of various market subsegments. The research methodology used to estimate the market size includes the following:

    Peritoneal Dialysis Market: Top-Down and Bottom-Up Approach

    Peritoneal Dialysis Market Top Down and Bottom Up Approach

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown were used as needed to complete the market engineering process and derive precise statistics for all segments.

    Approach for deriving the market size and estimating market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined through a thorough analysis of their Peritoneal dialysis sales. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    Phototherapy involves the utilization of a specific wavelength of light for the treatment of various medical conditions (such as psoriasis, vitiligo, acne vulgaris, neonatal jaundice, cancer, and eczema) through exposure of the affected area of the body to a light source.

    Key Stakeholders

    • Peritoneal dialysis product manufacturers
    • Distributors, channel partners, and third-party suppliers
    • Peritoneal dialysis service providers
    • Dialysis research laboratories
    • Dialysis associations and organizations
    • Healthcare service providers (including hospitals and dialysis centers)
    • Dialysis nurses and nephrologists
    • Academic medical centers and universities
    • Business research and consulting service providers
    • Venture capitalists and other government funding organizations

    Report Objectives

    • To describe, analyze, and forecast the Peritoneal dialysis market, by offerings, modality, disease indication, end user, and region
    • To describe and forecast the Peritoneal dialysis market for key regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
    • To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing the growth of the Peritoneal dialysis market
    • To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s five forces, and prices pertaining to the market under study
    • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
    • To profile key players and comprehensively analyze their market shares and core competencies2 in the Peritoneal dialysis market
    • To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the Peritoneal dialysis market

    Available customizations:

    With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

    Product Analysis

    • Product matrix, which gives a detailed comparison of the product portfolios of each company

    Regional Analysis

    • Further breakdown of the Rest of Asia Pacific Peritoneal dialysis market into Vietnam, New Zealand, and others.
    • Further breakdown of the Rest of Latin America Peritoneal dialysis market into Colombia, Chile, Ecuador, and others.
    • Further breakdown of the Rest of Europe Peritoneal dialysis market into Belgium, Russia, the Netherlands, Switzerland, and others.

    Company Information

    • Detailed analysis and profiling of additional market players (up to 5)

    Get the Full Peritoneal Dialysis Market Report

    Full forecast, segment splits, and company analysis for all Peritoneal Dialysis Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status